Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh have collectively filed a Schedule 13G with the United States Securities and Exchange Commission (SEC) on February 14, 2024, indicating a shared voting and dispositive power over 6,912,502 shares of bluebird bio, Inc. This represents 6.32% of the company's common stock. The filing, which is required due to the event date of December 31, 2023, signifies that the reporting persons have crossed the threshold of beneficial ownership that necessitates disclosure under the Securities Exchange Act of 1934. The shares are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. The principal business office for all reporting persons is located at 77 West Wacker Drive...Show More

Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh have collectively filed a Schedule 13G with the United States Securities and Exchange Commission (SEC) on February 14, 2024, indicating a shared voting and dispositive power over 6,912,502 shares of bluebird bio, Inc. This represents 6.32% of the company's common stock. The filing, which is required due to the event date of December 31, 2023, signifies that the reporting persons have crossed the threshold of beneficial ownership that necessitates disclosure under the Securities Exchange Act of 1934. The shares are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. The principal business office for all reporting persons is located at 77 West Wacker Drive, 7th Floor, Chicago, IL 60601. Alyeska Investment Group, L.P. and Alyeska Fund GP, LLC are organized in Delaware, while Anand Parekh is a citizen of the United States of America. The filing indicates that Alyeska Investment Group, L.P. is an investment adviser and a parent holding company or control person as per the SEC rules.